MediPost Rises 5.3% on Umbilical Cord Blood Theme Uptrend

On the 4th, the umbilical cord blood theme rose 3.09% compared to the previous day, showing strength, while Medipost, which is attracting attention as a related stock, surged 5.3% compared to the previous day. Medipost is known as a stem cell specialized company.

[Graph] Major stock price changes in the umbilical cord blood theme

According to preliminary data compiled at 11:09, foreigners are net selling -8,100 shares of Medipost.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Medipost’s quant financial score is 11.57 points, which is lower in stability, profitability, and growth scores compared to the average of other umbilical cord blood-related stocks. This can be interpreted as Medipost having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, Cha Biotech ranked first in quant financial ranking with higher growth and stability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.